These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 176266)

  • 1. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
    Blair PB; Lane MA
    J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytotoxic effector cells in the mouse mammary tumor system.
    Lane MA; Roubinian J; Slomich M; Trefts P; Blair PB
    J Immunol; 1975 Jan; 114(1 Pt 1):24-9. PubMed ID: 46242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural immunity in the oncornavirus-infected mouse.
    Blair PB
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
    Gillette RW; Lowery LT
    Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of immune mechanisms against mammary tumors by incomplete T cell depletion.
    Roubinian JR; Lane MA; Slomich M; Blair PB
    J Immunol; 1976 Nov; 117(5 Pt.2):1767-73. PubMed ID: 186535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age- and tumor-correlated changes in functional antibody responses to MTV in neonatally infected mice.
    Blair PB; Lane MA
    Int J Cancer; 1980 Feb; 25(2):273-9. PubMed ID: 6248467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.